Inventor · disambiguated record
Yong-Jun Liu
Also filed as: LIU YONG · LIU YONG-JUN
28 granted patents·26 pending applications·396 citations·filing 2001–2022
97Inventor score
Top patents by PatentIndex Score
54 records- 0197US9163085B2Anti-OX40 antibodies and methods of treating cancerLIU YONG-JUN·Filed 2012·Granted Oct 20, 2015·94 cites·7 claims
- 0297US9006399B2Anti-OX40 antibodies and methods of using the sameLIU YONG-JUN·Filed 2011·Granted Apr 14, 2015·114 cites·9 claims
- 0395US8614223B2Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereofVAN DUZER JOHN H·Filed 2011·Granted Dec 24, 2013·34 cites·16 claims
- 0493US9527917B2Nucleic acid encoding anti-OX40 antibodiesUNIV TEXAS·Filed 2015·Granted Dec 27, 2016·12 cites·17 claims
- 0592US9695246B2Anti-OX40 antibodies and methods of using the sameUNIV TEXAS·Filed 2015·Granted Jul 4, 2017·10 cites·9 claims
- 0690US10851173B2Anti-OX40 antibodies and methods of using the sameUNIV TEXAS·Filed 2018·Granted Dec 1, 2020·3 cites·12 claims
- 0790US6660523B2Dendritic cells; methodsSCHERING CORP·Filed 2001·Granted Dec 9, 2003·36 cites·7 claims
- 0889US7271248B2Human receptor proteins; related reagents and methodsSCHERING CORP·Filed 2004·Granted Sep 18, 2007·25 cites·12 claims
- 0989US6890734B2Nucleic acids encoding a cytokine receptor complexSCHERING CORP·Filed 2001·Granted May 10, 2005·16 cites·9 claims
- 1088US9409890B2Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2013·Granted Aug 9, 2016·9 cites·8 claims
- 1187US9303017B22,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereofUNIV GEORGETOWN·Filed 2012·Granted Apr 5, 2016·5 cites·15 claims
- 1282US7569224B2Mammalian cytokines; receptors; related reagents and methodsSCHERING CORP·Filed 2005·Granted Aug 4, 2009·5 cites·9 claims
- 1382US7071308B2Cytokine receptorSCHERING CORP·Filed 2004·Granted Jul 4, 2006·13 cites·2 claims
- 1481US7670603B2Human DNAX toll-like receptor 4 proteins, related reagents and methodsSCHERING CORP·Filed 2008·Granted Mar 2, 2010·3 cites·3 claims
- 1579US11174250B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted Nov 16, 2021·3 cites·23 claims
- 1676US9993465B22,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereofUNIV GEORGETOWN·Filed 2016·Granted Jun 12, 2018·1 cites·28 claims
- 1774US6913924B2Population of interferon producing cellsSCHERING CORP·Filed 2003·Granted Jul 5, 2005·4 cites·7 claims
- 1873US8075886B2Method of treatment using an anti-IL-B50 antibodyRECHE-GALLARDO PEDRO A·Filed 2009·Granted Dec 13, 2011·2 cites·4 claims
- 1972US6933369B2Mammalian proteinases; oxidoreductases; related reagentsSCHERING CORP·Filed 2003·Granted Aug 23, 2005·4 cites·5 claims
- 2070US9890137B22-halo-5-alkynyl-pyridyl nicotinic ligandsUNIV GEORGETOWN·Filed 2014·Granted Feb 13, 2018·1 cites·11 claims
- 2169US7928198B2IL-B50 polypeptideSCHERING CORP·Filed 2008·Granted Apr 19, 2011·0 cites·2 claims
- 2268US11319299B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted May 3, 2022·1 cites·39 claims
- 2368US9422355B2Antibodies to IL-B50BAZAN J FERNANDO·Filed 2008·Granted Aug 23, 2016·0 cites·7 claims
- 2465US10167339B2Antagonistic anti-OX40L antibodies and methods of their useBAYLOR RES INSTITUTE·Filed 2015·Granted Jan 1, 2019·1 cites·16 claims
- 2564US10196450B2Anti-OX40 antibodies and methods of using the sameUNIV TEXAS·Filed 2017·Granted Feb 5, 2019·0 cites·11 claims
- 2663US2004091970A1Mammalian cytokines; related reagents and methodsSCHERING CORP A NEW JERSEY COR·Filed 2003·Application pending·0 cites
- 2763US2007048781A1Mammalian cytokines; related reagents and methodsSCHERING CORP·Filed 2006·Application pending·0 cites
- 2862US2014093875A1Mammalian cytokines; receptors; related reagents and methodsMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 2961US12264147B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·2 claims
- 3061US2009017018A1Uses of mammalian cytokine: related reagentsSCHERING CORP·Filed 2007·Application pending·0 cites
- 3157US2003099947A1Mammalian cytokines; related reagents and methodsFiled 2001·Application pending·0 cites
- 3256US2008025974A1Human Receptor Proteins; Related Reagents and MethodsHARDIMAN GERARD T·Filed 2007·Application pending·0 cites
- 3354US2012269825A1Methods of modulating the ox40 receptor to treat cancerLIU YONG-JUN·Filed 2012·Application pending·0 cites
- 3453US2023279092A1Immunocytokines for treatment of autoimmune and inflammatory conditionsVIELA BIO INC·Filed 2021·Application pending·0 cites
- 3553US2024092763A1Isoindolinone aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 3653US2011311558A1Recombinant Bone Marrow Stromal Antigen-2 in the Treatment of Autoimmune DiseasesCAO WEI·Filed 2009·Application pending·0 cites
- 3753US2024025887A1Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 3852US10570208B2Antagonistic anti-OX40L antibodies and methods of their useBAYLOR RES INSTITUTE·Filed 2018·Granted Feb 25, 2020·0 cites·20 claims
- 3952US2012177658A1Methods of treatment using an anti il b50 antibodyRECHE-GALLARDO PEDRO A·Filed 2011·Application pending·0 cites
- 4052US2010266599A1Human receptor proteins; related reagents and methodsSCHERING CORP·Filed 2010·Application pending·0 cites
- 4151US10407406B22-halo-5-alkynyl-pyridyl nicotinic ligandsUNIV GEORGETOWN·Filed 2018·Granted Sep 10, 2019·0 cites·22 claims
- 4251US2011008368A1Methods of modulating the ox40 receptor to treat cancerUNIV TEXAS·Filed 2010·Application pending·0 cites
- 4351US2007178093A1Lymphocytes; methodsSCHERING CORP·Filed 2007·Application pending·0 cites
- 4451US2003032090A1Human receptor proteins; related reagents and methodsSCHERING CORP A NEW JERSEY COR·Filed 2001·Application pending·0 cites
- 4550US2017096403A1Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4648US2003003579A1Dendritic cells; methodsFiled 2001·Application pending·0 cites
- 4747US2005048054A1Lymphocytes; methodsFiled 2004·Application pending·0 cites
- 4847US2008286286A1Methods to Treat Disease States by Influencing the Signaling of Ox-40-Receptors and High Throughput Screening Methods for Identifying Substances ThereforUNIV TEXAS·Filed 2007·Application pending·0 cites
- 4945US2020385371A1Inhibitors of wdr5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 5044US2008199434A1Compositions and methods for the treatment of cardiovascular conditionsUNIV ARKANSAS·Filed 2007·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yong-Jun Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →